Astoria Event Highlights Thalassemia Health Needs
Patients and families met to discuss the management of this blood disorder and the need for regular medical care.
Updated on Oct. 29, 2026 in Asthma
Live Poll
Do you believe it is important to undergo genetic testing for unknown inherited health conditions?
An awareness event held in Astoria recently highlighted the challenges of managing thalassemia, an inherited blood disorder. The gathering brought together patients and families to discuss life with the condition and the necessity of ongoing medical support.
Why it matters
Thalassemia is caused by hemoglobin gene mutations that can lead to significant health complications, including iron overload and heart disease. Bringing awareness to this condition helps inform the public about the necessity of consistent care for those affected by the disorder.
Severe thalassemia is a lifelong condition that typically requires patients to receive blood transfusions every 14 to 21 days. While this regimen manages the blood disorder, the long-term effectiveness of alternative therapies like stem cell treatment remains under investigation.
The players
Maria Hadjidemetriou
A discussion leader who facilitated a session on the personal and medical realities of living with thalassemia.
Craig Butler
The National Executive Director of the Cooley's Anemia Foundation, an organization dedicated to supporting individuals with blood disorders.
Petroula Galanopoulos
A patient participant who is currently navigating the healthcare system while on a waiting list for stem cell treatment.
The details
Thalassemia occurs when mutations in the hemoglobin genes disrupt the body's ability to produce sufficient, healthy red blood cells. Patients with severe forms of the disorder rely on regular blood transfusions to maintain adequate oxygen levels, though this process can eventually lead to secondary complications. These include systemic iron overload, which may manifest as damage to the liver and heart, as well as potential growth delays in children.
Timeline
October 27, 2026: A thalassemia awareness event took place at Dionysos in Astoria.
Health Landscape
The Cooley's Anemia Foundation continues to drive public awareness to support patients navigating the complexities of chronic blood disorders. This work remains essential as the medical community explores curative options, such as stem cell therapy, to supplement traditional, long-term transfusion care.
If you are a carrier of the thalassemia trait, it is important to understand that you typically show no symptoms, though you can pass the gene to your children. Consult with a physician or genetic counselor to discuss potential family planning implications if you have been identified as a carrier.
The takeaway
Thalassemia requires a lifelong management plan due to its impact on hemoglobin production and the associated risks of iron overload. Patients should work closely with their medical team to monitor heart and liver health while staying informed about potential new treatments like stem cell therapy.
Further reading
For more information on managing chronic respiratory and blood-related health needs, visit Asthma.
More information
To learn more about the condition and support resources, visit the Cooley's Anemia Foundation information portal.
Source note: This article includes information reported by The National Herald.
Live Poll
Do you believe it is important to undergo genetic testing for unknown inherited health conditions?
